Hogge Gary S. - Insider Non-Derivative Transactions at Lineage Cell Therapeutics, Inc. (LCTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 11, 2023, Hogge Gary S.'s relationship to Lineage Cell Therapeutics, Inc. (LCTX) is Officer (SVP,Clinical & Medical Affairs), and currently has 13,020 shares of Common Shares, no par value.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LCTX insiders.
Data Source: SEC.
Hogge Gary S. - Insider Non-Derivative Transactions at LCTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 12, 2023 | F -- (Common Shares, no par value) | 5310 | 1.35 | 7710 |
| Feb 12, 2023 | M -- (Common Shares, no par value) | 13020 | 0 | 13020 |